The future of work is here. Discover the 37 top robotics and automation stocks leading the charge in AI-driven automation and industrial transformation.
For someone considering Haw Par, the big picture still revolves around owning a conservatively run business that combines established healthcare brands with a sizeable investment portfolio and a consistent dividend record. The latest half-year result, with softer sales and a clear step down in basic EPS, puts more focus on whether recent profitability can support that story in the near term. Short term, the key catalysts investors were watching, such as earnings stability and the ability to keep funding dividends out of ongoing cash generation, now look less straightforward but not necessarily broken, especially given the share price has only eased modestly in recent weeks. Instead, this news mainly sharpens existing risks: slower profit growth, relatively low return on equity and a valuation that is not obviously cheap.
However, one risk now feels more pressing than before: the pressure on Haw Par’s earnings resilience. Haw Par's share price has been on the slide but might be dropping deeper into value territory. Find out whether it's a bargain at this price.Explore 2 other fair value estimates on Haw Par - why the stock might be worth as much as 33% more than the current price!
Disagree with this assessment? Extraordinary investment returns rarely come from following the herd, so go with your instincts.
Our top stock finds are flying under the radar-for now. Get in early:
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com